Skip to Main Content

Paper Details

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment.
Clin Cancer Res
22
2022
Author NameAffiliation
Martijn P LolkemaErasmus Medical Center Cancer Institute
Martijn P LolkemaCenter for Personalized Cancer Treatment
Edwin CuppenOncode Institute, the Netherlands Cancer Institute
Edwin CuppenHartwig Medical Foundation
Edwin CuppenCenter for Molecular Medicine, University Medical Center Utrecht
Emile E VoestNetherlands Cancer Institute Amsterdam
Emile E VoestOncode Institute, the Netherlands Cancer Institute
Emile E VoestCenter for Personalized Cancer Treatment
  • 1 - 8

Datasets

Release 1.2